Biostatistician - Bilingual Mandarin
SystImmune
This listing was originally posted on SystImmune's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moSystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success.
The biostatistician will collaborate with the senior level biostatisticians on clinical or non-clinical studies. The successful candidate for this position will leverage data science and statistics expertise to support the data cleaning, visualization, analysis, and reporting for new drug discovery efforts.
This position requires a full-time onsite presence at our Redmond, WA office location.
Responsibilities:
Qualifications:
We offer an opportunity for you to learn and grow while making significant contributions to the company’s success.
SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at SystImmune?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Novel therapeutic bi-specific, and multi-specific antibodies, antibody-drug conjugates
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo